These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 741898)

  • 1. [Pharmacokinetics of lidocaine after intravenous and oral administration in patients with liver cirrhosis].
    Fuchshofen M; Zilly W; Epping J; Richter E
    Verh Dtsch Ges Inn Med; 1978; (84):1110-2. PubMed ID: 741898
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of oral lidocaine and nifedipine in patients with liver cirrhosis.
    Tonsuwannont W; Praisontarangkul OA; Manorot M; Klangwarnwong D
    J Med Assoc Thai; 1996 May; 79(5):309-19. PubMed ID: 8708523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.
    Okolicsanyi L; Venuti M; Strazzabosco M; Orlando R; Nassuato G; Iemmolo RM; Lirussi F; Muraca M; Pastorino AM; Castelli G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):329-32. PubMed ID: 6086536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs.
    Boyes RN; Adams HJ; Duce BR
    J Pharmacol Exp Ther; 1970 Jul; 174(1):1-8. PubMed ID: 5424701
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.
    Thomson PD; Melmon KL; Richardson JA; Cohn K; Steinbrunn W; Cudihee R; Rowland M
    Ann Intern Med; 1973 Apr; 78(4):499-508. PubMed ID: 4694036
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical applications of the pharmacokinetics of lidocaine.
    Benowitz NL
    Cardiovasc Clin; 1974; 6(2):77-101. PubMed ID: 4613465
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of ranitidine in cirrhotic patients with or without ascites].
    Reymann JM; Richard MO; Bretagne JF; Allain H; Bentue-Ferrer D; D'Athis P; Van den Driessche J
    Therapie; 1986; 41(3):173-8. PubMed ID: 3750255
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F
    Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in pharmacokinetics of trimecaine in patients with liver cirrhosis].
    Perlík F; Haller A; Brodanová M; Safarík L
    Sb Lek; 1991 Oct; 93(9-10):287-92. PubMed ID: 1821461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver.
    Hellstern A; Hellenbrecht D; Saller R; Gatzen M; Manus B; Achtert G; Brockmann P; Hausleiter HJ; Leuschner U
    Arzneimittelforschung; 1987 Jun; 37(6):733-6. PubMed ID: 3663273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
    Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
    Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lidocaine metabolism and liver histology.
    Fabbri A; Bianchi GP; Marchesini G
    Hepatology; 1995 Jun; 21(6):1761-2. PubMed ID: 7768525
    [No Abstract]   [Full Text] [Related]  

  • 16. Avoidance of "first-pass" elimination of rectally administered lidocaine in relation to the site of absorption in rats.
    de Leede LG; de Boer AG; Roozen CP; Breimer DD
    J Pharmacol Exp Ther; 1983 Apr; 225(1):181-5. PubMed ID: 6834271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastric acid secretion in cirrhotic patients following orally and parenterally-administered histamine].
    Freytes MA; Carri JH; Canet D
    Rev Esp Enferm Apar Dig; 1971 Jun; 34(6):641-6. PubMed ID: 5143445
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lidocaine pharmacokinetics when administered intramuscularly].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Metelitsa VI
    Farmakol Toksikol; 1980; 43(4):411-6. PubMed ID: 7439378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine elimination in patients with liver cirrhosis.
    Wójcicki J; Kozłowski K; Droździk M; Wójcicki M
    Acta Pol Pharm; 2002; 59(4):321-4. PubMed ID: 12403308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.